In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

Wearable equipment-based telemedical management via multiparameter monitoring can help improve management in older patients with coronary heart disease.

A scientific statement regarding clinical considerations for athletes with cardiovascular abnormalities has been published by the AHA and ACC.

Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care.

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

Electronic symptom monitoring with patient-reported outcomes (PRO) meaningfully improves clinical outcomes for cancer treatment.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified ...

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.